12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 102 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 31 publications that cite this research output.

31

The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis

Article in Frontiers in Neuroendocrinology (February 2024)

SGLT2 Inhibitor Canagliflozin Alleviates High Glucose-Induced Inflammatory Toxicity in BV-2 Microglia

Article in Biomedicines (December 2023)

GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes

Article in Diabetes & Metabolism (August 2023)